<VariationArchive VariationID="17091" VariationName="MLH1, EX16DEL" VariationType="Deletion" Accession="VCV000017091" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2020-11-28" MostRecentSubmission="2020-11-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32130" VariationID="17091">
      <GeneList>
        <Gene Symbol="MLH1" FullName="mutL homolog 1" GeneID="4292" HGNC_ID="HGNC:7127" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>3p22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="36993466" stop="37050846" display_start="36993466" display_stop="37050846" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="37034840" stop="37092336" display_start="37034840" display_stop="37092336" Strand="+" />
          </Location>
          <OMIM>120436</OMIM>
          <Haploinsufficiency last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MLH1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MLH1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>MLH1, EX16DEL</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p21.3</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>EX16DEL</Name>
      </OtherNameList>
      <XRefList>
        <XRef Type="Allelic variant" ID="120436.0014" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff could not confirm the published sequence change on a current reference sequence after review of PubMed 11389087.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="MLH1, EX16DEL AND Colorectal cancer, hereditary nonpolyposis, type 2" Accession="RCV000018622" Version="31">
        <ClassifiedConditionList TraitSetID="5637">
          <ClassifiedCondition DB="MedGen" ID="C1333991">Colorectal cancer, hereditary nonpolyposis, type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-06-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="MLH1, EX16DEL AND Mismatch repair cancer syndrome 1" Accession="RCV001267886" Version="1">
        <ClassifiedConditionList TraitSetID="455">
          <ClassifiedCondition DB="MedGen" ID="C5399763">Mismatch repair cancer syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-06-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2001-06-01" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2020-11-28" MostRecentSubmission="2020-11-28">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11389087</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5637" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4825" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MLH1-Related Lynch Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 2</ElementValue>
                <XRef Type="MIM" ID="609310" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary non-polyposis colorectal cancer, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Colorectal cancer, hereditary nonpolyposis, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lynch syndrome II</ElementValue>
                <Citation Type="general" Abbrev="Vasen et al., 2007">
                  <ID Source="pmc">2740877</ID>
                </Citation>
                <XRef ID="Colorectal+Cancer%2C+Hereditary+Nonpolyposis%2C+Type+2/1749" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FCC2</ElementValue>
                <XRef Type="MIM" ID="609310" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">LYNCH2</ElementValue>
                <XRef Type="MIM" ID="609310" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HNPCC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">COCA2</ElementValue>
                <XRef Type="MIM" ID="609310" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15457" />
                <XRef ID="15457" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MLH1-Related Hereditary Non-Polyposis Colon Cancer</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520048" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501796" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332358" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508796" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514698" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260599" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569423" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512645" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508803" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508795" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000326160" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528930" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528915" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512403" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501398" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508788" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508789" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528914" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000317453" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510417" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505560" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528529" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000595970" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501396" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512492" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, ovary, stomach, small bowel, urinary tract, biliary tract, brain (usually glioblastoma), skin (sebaceous adenomas, sebaceous carcinomas, and keratoacanthomas), pancreas, and prostate. Cancer risks and age of onset vary depending on the associated gene. Several other cancer types have been reported to occur in individuals with Lynch syndrome (e.g., breast, sarcomas, adrenocortical carcinoma). However, the data are not sufficient to demonstrate that the risk of developing these cancers is increased in individuals with Lynch syndrome.</Attribute>
                <XRef ID="NBK1211" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301390</ID>
                <ID Source="BookShelf">NBK1211</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743612</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2010">
                <ID Source="PubMed">20065170</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCRS, 2001">
                <ID Source="PubMed">11598466</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="AMA/NCHPEG, 2012">
                <URL>http://www.nchpeg.org/documents/crc/11-0456%20Fact%20sheets%20(MSI%20and%20IHC%20testing).pdf</URL>
              </Citation>
              <Citation Type="practice guideline" Abbrev="SGO, 2014">
                <URL>https://www.sgo.org/clinical-practice/guidelines/screening-for-lynch-syndrome-in-endometrial-cancer</URL>
                <CitationText>Society of Gynecologic Oncology (SGO) Clinical Practice Statement: Screening for Lynch Syndrome in Endometrial Cancer</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="MSTF, 2014">
                <ID Source="PubMed">25070057</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2014">
                <ID Source="PubMed">24493721</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2013">
                <ID Source="pmc">3585492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/ESMO, 2015">
                <ID Source="PubMed">25452455</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24310308</ID>
              </Citation>
              <Citation Type="general" Abbrev="Mork et al., 2015">
                <ID Source="PubMed">25711197</ID>
              </Citation>
              <Citation Type="general" Abbrev="Dutch SCG, 2013">
                <ID Source="PubMed">23535968</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="Mallorca group, 2013">
                <ID Source="PubMed">23408351</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC/CCA-ICC, 2012">
                <ID Source="PubMed">22167527</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers">
                <ID Source="PubMed">26389210</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2015">
                <ID Source="PubMed">26324357</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2020">
                <ID Source="PubMed">31672839</ID>
                <ID Source="pmc">7295005</ID>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Lynch-Syndrome.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, MLH1, MSH2, MSH6, PMS2, EPCAM Pathogenic Variants, Lynch Syndrome (Hereditary Non-polyposis Colon Cancer [HNPCC]), 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/dg42</URL>
                <CitationText>UK NICE Diagnostics Guidance DG42, Testing strategies for Lynch syndrome in people with endometrial cancer, 2020</CitationText>
              </Citation>
              <XRef ID="144" DB="Orphanet" />
              <XRef ID="C1333991" DB="MedGen" />
              <XRef ID="MONDO:0012249" DB="MONDO" />
              <XRef Type="MIM" ID="609310" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="455" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3207" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">BRAIN TUMOR-POLYPOSIS SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="276300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BTP1 SYNDROME</ElementValue>
                <XRef Type="MIM" ID="276300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHILDHOOD CANCER SYNDROME</ElementValue>
                <XRef Type="MIM" ID="276300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mismatch repair cancer syndrome 1</ElementValue>
                <XRef ID="MONDO:0010159" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MISMATCH REPAIR DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="276300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MMR DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="276300" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMMRDS</ElementValue>
                <XRef Type="MIM" ID="276300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MMRCS1</ElementValue>
                <XRef Type="MIM" ID="276300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BTPS1</ElementValue>
                <XRef Type="MIM" ID="276300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">MLH1-Related Hereditary Non-Polyposis Colon Cancer</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MLH1-Related Turcot Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, ovary, stomach, small bowel, urinary tract, biliary tract, brain (usually glioblastoma), skin (sebaceous adenomas, sebaceous carcinomas, and keratoacanthomas), pancreas, and prostate. Cancer risks and age of onset vary depending on the associated gene. Several other cancer types have been reported to occur in individuals with Lynch syndrome (e.g., breast, sarcomas, adrenocortical carcinoma). However, the data are not sufficient to demonstrate that the risk of developing these cancers is increased in individuals with Lynch syndrome.</Attribute>
                <XRef ID="NBK1211" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000527984" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501797" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000317455" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501396" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000595970" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000328927" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501398" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501399" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000317457" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528930" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528914" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528912" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530202" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515899" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000518997" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501400" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527981" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501424" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528519" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501401" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527982" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569423" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528915" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515534" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501402" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="420" />
                <XRef ID="420" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301390</ID>
                <ID Source="BookShelf">NBK1211</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/ESMO, 2015">
                <ID Source="PubMed">25452455</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC/CCA-ICC, 2012">
                <ID Source="PubMed">22167527</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Lynch-Syndrome.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, MLH1, MSH2, MSH6, PMS2, EPCAM Pathogenic Variants, Lynch Syndrome (Hereditary Non-polyposis Colon Cancer [HNPCC]), 2019</CitationText>
              </Citation>
              <XRef ID="252202" DB="Orphanet" />
              <XRef ID="C5399763" DB="MedGen" />
              <XRef ID="MONDO:0010159" DB="MONDO" />
              <XRef Type="MIM" ID="276300" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38905" SubmissionDate="2020-11-24" DateLastUpdated="2020-11-28" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="120436.0014_COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2" title="MLH1, EX16DEL_COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2" />
        <ClinVarAccession Accession="SCV000038905" DateUpdated="2020-11-28" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Vilkki et al. (2001) identified a homozygous deletion of exon 16 of the MLH1 gene in a 4-year-old girl who died unexpectedly of brain hemorrhage caused by glioma. She also had cafe-au-lait spots, including multiple axillary freckles characteristic of NF1 (see 162200) without other features of NF1. The phenotype in this girl was consistent with the spectrum of mismatch repair cancer syndrome (MMRCS1; 276300). Both parents, who had family histories of hereditary nonpolyposis colorectal cancer (HNPCC2; 609310), were heterozygous for the deletion.</Attribute>
              <Citation>
                <ID Source="PubMed">11389087</ID>
              </Citation>
              <XRef DB="OMIM" ID="162200" Type="MIM" />
              <XRef DB="OMIM" ID="276300" Type="MIM" />
              <XRef DB="OMIM" ID="609310" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLH1" />
          </GeneList>
          <Name>MLH1, EX16DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX16DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="120436.0014" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2856751" SubmissionDate="2020-11-24" DateLastUpdated="2020-11-28" DateCreated="2020-11-28">
        <ClinVarSubmissionID localKey="120436.0014_MISMATCH REPAIR CANCER SYNDROME 1" title="MLH1, EX16DEL_MISMATCH REPAIR CANCER SYNDROME 1" />
        <ClinVarAccession Accession="SCV001446365" DateUpdated="2020-11-28" DateCreated="2020-11-28" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Vilkki et al. (2001) identified a homozygous deletion of exon 16 of the MLH1 gene in a 4-year-old girl who died unexpectedly of brain hemorrhage caused by glioma. She also had cafe-au-lait spots, including multiple axillary freckles characteristic of NF1 (see 162200) without other features of NF1. The phenotype in this girl was consistent with the spectrum of mismatch repair cancer syndrome (MMRCS1; 276300). Both parents, who had family histories of hereditary nonpolyposis colorectal cancer (HNPCC2; 609310), were heterozygous for the deletion.</Attribute>
              <Citation>
                <ID Source="PubMed">11389087</ID>
              </Citation>
              <XRef DB="OMIM" ID="162200" Type="MIM" />
              <XRef DB="OMIM" ID="276300" Type="MIM" />
              <XRef DB="OMIM" ID="609310" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MLH1" />
          </GeneList>
          <Name>MLH1, EX16DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX16DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="120436.0014" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">MISMATCH REPAIR CANCER SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2856751" TraitType="Disease" MappingType="Name" MappingValue="MISMATCH REPAIR CANCER SYNDROME 1" MappingRef="Alternate">
        <MedGen CUI="C5399763" Name="Mismatch repair cancer syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="38905" TraitType="Disease" MappingType="Name" MappingValue="COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2" MappingRef="Preferred">
        <MedGen CUI="C1333991" Name="Colorectal cancer, hereditary nonpolyposis, type 2" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="4" DateDeleted="2020-11-26">SCV000038906</Accession>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

